Overview

Clinical Trial of Efficacy and Safety of Rengalin in the Treatment of Cough in Patients With Chronic Obstructive Pulmonary Disease

Status:
Completed
Trial end date:
2019-04-25
Target enrollment:
Participant gender:
Summary
The purpose of this study is to obtain additional data on efficacy and safety of Rengalin in the treatment of cough in patients with stable obstructive pulmonary disease
Phase:
Phase 4
Details
Lead Sponsor:
Materia Medica Holding